Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

The cumulative incidence of National Institutes of Health (NIH)-defined chronic graft-versus-host disease (GVHD) requiring systemic treatment is ∼35% at 1 year after transplantation of granulocyte colony-stimulating factor (G-CSF)–mobilized blood cells from HLA-matched related or unrelated donors. W...

Full description

Saved in:
Bibliographic Details
Published in:Blood
Main Authors: Mielcarek, Marco, Furlong, Terry, O’Donnell, Paul V., Storer, Barry E., McCune, Jeannine S., Storb, Rainer, Carpenter, Paul A., Flowers, Mary E. D., Appelbaum, Frederick R., Martin, Paul J.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2016
Subjects:
Transplantation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4797026/
https://ncbi.nlm.nih.gov/pubmed/26764356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-10-672071
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items